Luise Tittl

1.6k total citations · 1 hit paper
40 papers, 1.2k citations indexed

About

Luise Tittl is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Luise Tittl has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 27 papers in Internal Medicine and 6 papers in Hematology. Recurrent topics in Luise Tittl's work include Atrial Fibrillation Management and Outcomes (37 papers), Venous Thromboembolism Diagnosis and Management (27 papers) and Cardiac Arrhythmias and Treatments (12 papers). Luise Tittl is often cited by papers focused on Atrial Fibrillation Management and Outcomes (37 papers), Venous Thromboembolism Diagnosis and Management (27 papers) and Cardiac Arrhythmias and Treatments (12 papers). Luise Tittl collaborates with scholars based in Germany, United Kingdom and Switzerland. Luise Tittl's co-authors include Jan Beyer‐Westendorf, Franziska Michalski, Kurtuluş Şahin, Sebastian Werth, Sandra Marten, Sven Pannach, Vera Gelbricht, Franziska Ebertz, Christina Köhler and Norbert Weiss and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and European Heart Journal.

In The Last Decade

Luise Tittl

36 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

2014 311 citations Jan Beyer‐Westendorf, Sven Pannach et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luise Tittl Germany	16	1.0k	771	137	114	69	40	1.2k
Franziska Michalski Germany	7	746 0.7×	528 0.7×	95 0.7×	64 0.6×	53 0.8×	12	814
Marjolein Brekelmans Netherlands	14	368 0.4×	476 0.6×	108 0.8×	165 1.4×	45 0.7×	19	628
N. Ruiz‐Giménez Spain	11	615 0.6×	748 1.0×	113 0.8×	194 1.7×	105 1.5×	19	845
Judy Kovacs Canada	8	412 0.4×	540 0.7×	125 0.9×	161 1.4×	71 1.0×	13	646
J S Ginsberg Canada	7	391 0.4×	454 0.6×	151 1.1×	143 1.3×	30 0.4×	9	594
Betsy MacKinnon Canada	10	820 0.8×	1.2k 1.5×	355 2.6×	568 5.0×	62 0.9×	13	1.3k
Kristine Hommel Denmark	12	864 0.8×	371 0.5×	17 0.1×	51 0.4×	236 3.4×	25	1.2k
C. Suárez Spain	14	370 0.4×	335 0.4×	66 0.5×	175 1.5×	84 1.2×	39	776
Jannik Langtved Pallisgaard Denmark	21	957 0.9×	288 0.4×	29 0.2×	144 1.3×	111 1.6×	64	1.2k
Alexander GG Turpie Canada	9	1.3k 1.3×	1.5k 2.0×	203 1.5×	510 4.5×	171 2.5×	17	1.7k

Countries citing papers authored by Luise Tittl

Since Specialization

Citations

This map shows the geographic impact of Luise Tittl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luise Tittl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luise Tittl more than expected).

Fields of papers citing papers by Luise Tittl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luise Tittl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luise Tittl. The network helps show where Luise Tittl may publish in the future.

Co-authorship network of co-authors of Luise Tittl

This figure shows the co-authorship network connecting the top 25 collaborators of Luise Tittl. A scholar is included among the top collaborators of Luise Tittl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luise Tittl. Luise Tittl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tittl, Luise, et al.. (2024). Patterns of atrial fibrillation anticoagulation with rivaroxaban — 7-year follow-up from the Dresden NOAC registry. Thrombosis Research. 236. 61–67.

Müller, Stephanie, Luise Tittl, Lara N. Roberts, et al.. (2022). Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry. Research and Practice in Thrombosis and Haemostasis. 6(7). e12829–e12829. 2 indexed citations

Tittl, Luise, et al.. (2021). 5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC Registry. Thrombosis Research. 202. 24–30. 7 indexed citations

Marten, Sandra, et al.. (2021). Long-term VTE treatment with rivaroxaban: Results from the DRESDEN NOAC REGISTRY. Thrombosis Research. 208. 181–189.

Beyer‐Westendorf, Jan, et al.. (2020). Rates, management and outcome of bleeding complications during edoxaban therapy in daily care – results from the DRESDEN NOAC REGISTRY. Thrombosis Research. 190. 91–98. 5 indexed citations

Beyer‐Westendorf, Jan, Luise Tittl, Ingrid M. Bistervels, et al.. (2020). Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort study. The Lancet Haematology. 7(12). e884–e891. 40 indexed citations

Tittl, Luise, et al.. (2019). DTI/DXI interferences with global coagulation tests in emergency hospital admissions - Results of the prospective Dresden NOAC Registry (NCT01588119). Thrombosis Research. 182. 101–109. 3 indexed citations

Tittl, Luise, et al.. (2018). Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119). International Journal of Cardiology. 262. 85–91. 67 indexed citations

Marten, Sandra, et al.. (2018). Venous thromboembolism therapy with rivaroxaban in daily-care patients: Results from the Dresden NOAC registry. International Journal of Cardiology. 257. 276–282. 21 indexed citations

10.

Pannach, Sven, et al.. (2017). Gastrointestinal endoscopy in patients receiving novel direct oral anticoagulants: results from the prospective Dresden NOAC registry. Journal of Gastroenterology. 53(2). 236–246. 17 indexed citations

11.

Pannach, Sven, et al.. (2017). Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs. Journal of Gastroenterology. 52(12). 1211–1220. 31 indexed citations

12.

Hecker, Judith S., Sandra Marten, Franziska Michalski, et al.. (2016). Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Thrombosis and Haemostasis. 115(5). 939–949. 115 indexed citations

13.

Michalski, Franziska, Luise Tittl, Saskia Middeldorp, et al.. (2016). Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting. Thrombosis and Haemostasis. 116(10). 651–658. 75 indexed citations

14.

Beyer‐Westendorf, Jan, S. Gehrisch, Thoralf Stange, et al.. (2015). Coagulation activation after discontinuation of VTE treatment with different oral anticoagulants and impact on 12-month clinical outcomes. Thrombosis Research. 136(2). 261–266. 6 indexed citations

15.

Ebertz, Franziska, Vera Gelbricht, Franziska Michalski, et al.. (2015). Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Thrombosis and Haemostasis. 113(6). 1247–1257. 115 indexed citations

16.

Förster, K., Thomas Schreier, Franziska Michalski, et al.. (2015). Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry. EP Europace. 17(4). 530–538. 119 indexed citations

17.

Ebertz, Franziska, Sebastian Werth, Christina Köhler, et al.. (2014). Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119). Blood. 124(21). 1541–1541. 3 indexed citations

18.

Beyer‐Westendorf, Jan, Sven Pannach, Franziska Ebertz, et al.. (2014). Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood. 124(6). 955–962. 311 indexed citations breakdown →

19.

Lützner, Jörg, Lars Donath, Luise Tittl, et al.. (2012). Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery. Thrombosis and Haemostasis. 109(1). 154–163. 43 indexed citations

20.

Gelbricht, Vera, et al.. (2012). Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119). Blood. 120(21). 1173–1173. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact